Expanding Horizons in Toric IOLs: Translating Technological Advances Into Improved Patient Outcomes

Release Date: March 31, 2025

Expiration Date: March 31, 2026

Activity Overview

Cataracts are the leading cause of treatable vision loss in the United States, with approximately 4 million people undergoing cataract surgery annually. In patients with concurrent astigmatism, use of a toric intraocular lens (IOL) during cataract surgery is a safe and highly effective intervention with a relatively fast postoperative recovery. However, given the myriad of IOLs on the market, appropriate patient selection and knowledge of the available products is essential for delivering the highest quality patient-centered care.

This Community Practice Connections™ program provides an in-depth review of some of the key highlights from a live symposium presented at the EnVision 2025 Summit held in February. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with cataracts and coexisting astigmatism, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Target Audience

This live educational activity is directed toward ophthalmologists, optometrists, and other eye care professionals.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Differentiate between available IOL products with respect to materials technology and design
• Identify patients with astigmatism who are appropriate candidates for IOL surgery
• Select appropriate IOLs based on patient presentation and goals of therapy

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible companies.

PER^® mitigated all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.